A B M Brandão
Biographic Data
| ID | 6163244 |
|---|---|
| NAME | A B M Brandão |
| GIVEN NAMES | A B M |
| FAMILY NAME | Brandão |
| SIGNATURE | BRANDÃO A B M |
| AFFILIATIONS | Universidade Federal de Ciências da Saúde de Porto Alegre |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 0 |
P2-356 Independent predictors of metabolic syndrome in HIV-infected patients
Introduction Metabolic Syndrome (MetS) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease. However, a few studies have assessed its prevalence and risk factors among HIV patients from developing countries. Objective To identify independent risk factors for metabolic syndrome by the criteria of the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) among men and wo…
SP4-37 Metabolic syndrome prevalence and population attributable risk among HIV/Aids patients
Background Metabolic syndrome comprises a set of aggregated risk factors, which increase the risk of cardiovascular disease and type 2 diabetes mellitus, and changes in the abnormality criteria account for differences in prevalence rates and in the population attributable risk. Objectives Verify the prevalence of metabolic syndrome according to the NCEP-ATPIII, IDF and the AHA/NHLBI, and the impact of each component on the diagnostic of metabolic…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
No prominent works on this page.
P2-356 Independent predictors of metabolic syndrome in HIV-infected patients
Introduction Metabolic Syndrome (MetS) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease. However, a few studies have assessed its prevalence and risk factors among HIV patients from developing countries. Objective To identify independent risk factors for metabolic syndrome by the criteria of the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) among men and wo…
SP4-37 Metabolic syndrome prevalence and population attributable risk among HIV/Aids patients
Background Metabolic syndrome comprises a set of aggregated risk factors, which increase the risk of cardiovascular disease and type 2 diabetes mellitus, and changes in the abnormality criteria account for differences in prevalence rates and in the population attributable risk. Objectives Verify the prevalence of metabolic syndrome according to the NCEP-ATPIII, IDF and the AHA/NHLBI, and the impact of each component on the diagnostic of metabolic…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
Cross-sectional study (3 works) · Diabetes, Cardiovascular Risks, and Lipoproteins (3 works) · HIV-related health complications and treatments (3 works) · Internal Medicine (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Obesity (3 works) · Diabetes mellitus (2 works) · Endocrinology (2 works) · Endocrinology (2 works)